83 FR 14505 - Importer of Controlled Substances Application: Wildlife Laboratories Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 65 (April 4, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 65 (April 4, 2018)
| Page Range | 14505-14505 | |
| FR Document | 2018-06871 |
[Federal Register Volume 83, Number 65 (Wednesday, April 4, 2018)] [Notices] [Page 14505] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-06871] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Wildlife Laboratories Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 4, 2018. Such persons may also file a written request for a hearing on the application on or before May 4, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on February 6, 2018 Wildlife Laboratroies Inc., 1230 West Ash, Suite D Windsor, CO 80550 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Etorphine HCl........................ 9059 II Thiafentanil......................... 9729 II ------------------------------------------------------------------------ The company plans to import the listed controlled substances for distribution to its customers. Dated: March 27, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-06871 Filed 4-3-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 65 / Wednesday, April 4, 2018 / Notices 14505
revocation of registration) has been Attn: DEA Federal Register engage in transactions that would
redelegated to the Assistant Representative/DRW, 8701 Morrissette otherwise be prohibited provided the
Administrator of the DEA Diversion Drive, Springfield, Virginia 22152. conditions stated there in are met. This
Control Division (‘‘Assistant SUPPLEMENTARY INFORMATION: The notice includes the following proposed
Administrator’’) pursuant to section 7 of Attorney General has delegated his exemptions: D–11890, Liberty Media
28 CFR part 0, appendix to subpart R. authority under the Controlled 401(k) Savings Plan; D–11931, CLS
In accordance with 21 CFR Substances Act to the Administrator of Investments, LLC and Affiliates.
1301.34(a), this is notice that on January the Drug Enforcement Administration DATES: All interested persons are invited
17, 2018, Catalent Pharma Solutions, (DEA), 28 CFR 0.100(b). Authority to to submit written comments or requests
LLC, 3031 Red Lion Road, Philadelphia, exercise all necessary functions with for a hearing on the pending
Pennsylvania 19114 applied to be respect to the promulgation and exemptions, unless otherwise stated in
registered as an importer of Gamma implementation of 21 CFR part 1301, the Notice of Proposed Exemption,
Hydroxybutyric Acid (2010), a basic incident to the registration of within 45 days from the date of
class of controlled substance listed in manufacturers, distributors, dispensers, publication of this Federal Register
schedule I. importers, and exporters of controlled Notice.
The company plans to import finished substances (other than final orders in ADDRESSES: Comments and requests for
dosage unit products containing gamma- connection with suspension, denial, or a hearing should state: (1) The name,
hydroxybutyric acid for clinical trials, revocation of registration) has been address, and telephone number of the
research, and analytical activities. redelegated to the Assistant
Approval of permit applications will person making the comment or request,
Administrator of the DEA Diversion and (2) the nature of the person’s
occur only when the registrant’s Control Division (‘‘Assistant
business activity is consistent with what interest in the exemption and the
Administrator’’) pursuant to section 7 of manner in which the person would be
is authorized under to 21 U.S.C. 28 CFR part 0, appendix to subpart R.
952(a)(2). Authorization will not extend adversely affected by the exemption. A
In accordance with 21 CFR request for a hearing must also state the
to the import of FDA approved or non- 1301.34(a), this is notice that on
approved finished dosage forms for issues to be addressed and include a
February 6, 2018 Wildlife Laboratroies general description of the evidence to be
commercial sale. Inc., 1230 West Ash, Suite D Windsor, presented at the hearing.
Dated: March 27, 2018. CO 80550 applied to be registered as an All written comments and requests for
Susan A. Gibson, importer of the following basic classes a hearing (at least three copies) should
Deputy Assistant Administrator. of controlled substances: be sent via mail to the Employee
[FR Doc. 2018–06872 Filed 4–3–18; 8:45 am] Benefits Security Administration
Controlled (EBSA), Office of Exemption
BILLING CODE 4410–09–P Drug code Schedule
substance
Determinations, U.S. Department of
Etorphine HCl ....... 9059 II Labor, 200 Constitution Avenue NW,
DEPARTMENT OF JUSTICE Thiafentanil ........... 9729 II Suite 400, Washington, DC 20210.
Attention: Application No.ll, stated
Drug Enforcement Administration The company plans to import the in each Notice of Proposed Exemption
[Docket No. DEA–392] listed controlled substances for or via private delivery service or courier
distribution to its customers. to the Employee Benefits Security
Importer of Controlled Substances Dated: March 27, 2018. Administration (EBSA), Office of
Application: Wildlife Laboratories Inc. Exemption Determinations, U.S.
Susan A. Gibson,
Department of Labor, 122 C St. NW,
ACTION: Notice of application. Deputy Assistant Administrator.
Suite 400, Washington, DC 20001.
[FR Doc. 2018–06871 Filed 4–3–18; 8:45 am] Attention: Application No.ll, stated
DATES: Registered bulk manufacturers of BILLING CODE 4410–09–P in each Notice of Proposed Exemption.
the affected basic classes, and Interested persons are also invited to
applicants therefore, may file written submit comments and/or hearing
comments on or objections to the DEPARTMENT OF LABOR requests to EBSA via email or FAX. Any
issuance of the proposed registration on such comments or requests should be
or before May 4, 2018. Such persons Employee Benefits Security sent either by email to: e-OED@dol.gov,
may also file a written request for a Administration by FAX to (202) 693–8474, or online
hearing on the application on or before through http://www.regulations.gov by
May 4, 2018. Proposed Exemptions From Certain
the end of the scheduled comment
Prohibited Transaction Restrictions
ADDRESSES: Written comments should period. The applications for exemption
be sent to: Drug Enforcement AGENCY: Employee Benefits Security and the comments received will be
Administration, Attention: DEA Federal Administration, Labor. available for public inspection in the
Register Representative/DRW, 8701 ACTION: Notice of Proposed Exemptions. Public Documents Room of the
Morrissette Drive, Springfield, Virginia Employee Benefits Security
22152. All requests for hearing must be SUMMARY: This document contains Administration, U.S. Department of
sent to: Drug Enforcement notices of pendency before the Labor, Room N–1515, 200 Constitution
Administration, Attn: Administrator, Department of Labor (the Department) of Avenue NW, Washington, DC 20210.
amozie on DSK30RV082PROD with NOTICES
8701 Morrissette Drive, Springfield, proposed exemptions from certain of the Warning: All comments will be made
Virginia 22152. All request for hearing prohibited transaction restrictions of the available to the public. Do not include
should also be sent to: (1) Drug Employee Retirement Income Security any personally identifiable information
Enforcement Administration, Attn: Act of 1974 (ERISA or the Act) and/or (such as Social Security number, name,
Hearing Clerk/LJ, 8701 Morrissette the Internal Revenue Code of 1986 (the address, or other contact information) or
Drive, Springfield, Virginia 22152; and Code). If granted, these proposed confidential business information that
(2) Drug Enforcement Administration, exemptions allow designated parties to you do not want publicly disclosed. All
VerDate Sep<11>2014 18:12 Apr 03, 2018 Jkt 244001 PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1](https://thefederalregister.org/doc/83_FR_14570/page/1.svg)
Document Created: 2018-11-01 09:11:26
Document Modified: 2018-11-01 09:11:26
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 4, 2018. Such persons may also file a written request for a hearing on the application on or before May 4, 2018. | |
| FR Citation | 83 FR 14505 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR